Gabapentin is a prescription drug for neuropathic pain and seizure disorders, but it is classified as a Schedule V controlled substance in some states. It may have a low potential for abuse, but it can also be diverted and misused, especially with opioids. Gabapentin is not currently controlled under the Controlled Substances Act of 1970. Following concerns about abuse, gabapentin has been reclassified as a Class C controlled substance and is now a Schedule 3 drug, but is exempt from safe custody requirements. Healthcare professionals should evaluate patients carefully for a history of drug abuse before prescribing gabapentin, and observe patients for signs of abuse and dependence. Gabapentin is a medication for nerve pain and seizures that can cause euphoria or relaxation. It’s not a controlled substance by the federal government, but eight states classify it as a schedule V substance with stricter laws. Presently, seven states have classified gabapentin as a Schedule V controlled substance, and 12 others, New Jersey included, require that gabapentin prescriptions be reported in the PDMP system. Every time a prescription for gabapentin is filled out, it will automatically be added to the database. Effective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. It is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. While gabapentin remains a non-controlled substance, Session Law 2023-65 Part XI Section 11.1 G.S. 90-113.73(b) adds it to the medications recorded in NC CSRS because it may cause a level of sedation in patients that puts them at increased risk of overdose when taken with opioids. The NC Department of Health and Human Services (NCDHHS) has Gabapentin isn’t a narcotic or federally controlled substance, but it is regulated and recognized as a controlled substance in certain states. Gabapentin is approved by the Food and Gabapentin is a medication for nerve pain and seizures that can be harmful when combined with opioids. Michigan has modified its Pharmacy Rules to categorize Gabapentin as a controlled substance and improve training standards for prescribers and dispensers of opioids. For controlled substance licensure, the rule changes require a designated prescriber to have a controlled substance license for a health facility if substances are stored there without an on-site pharmacy or an automated device stocked by a pharmacy, provide an exception to licensure for an emergency kit that contains controlled substances , any new orders for Gabapentin issued by a practitioner WITHOUT a Utah. Controlled Substance license and a DEA registration will not be valid and MAY NOT be administered or dispensed. Prescription orders (including refills) issued for Gabapentin prior to May 1 , 2024, will not be. aected. It is not legal to distribute Gabapentin samples in Utah. Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). Gabapentin is not a controlled substance under federal law, but some states classify it as a Schedule V drug or a drug of concern. Learn about the products, indications, risks, and reporting requirements of gabapentin in different states. Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970.11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored At the time of this writing, gabapentin (Neurontin) is not considered to be a controlled substance on the federal level. However, some states, such as Michigan, and other municipalities, have scheduled it as a class 5 drug, meaning it is believed to have a relatively low potential for abuse. Effective July 1, 2018, all gabapentin products will be Schedule V controlled substances in the state of Tennessee. It is known under the brand names Neurontin, Horizant, Gralise, Gabarone, and Fanatrex. At the national level, gabapentin is not classified as a controlled substance under the Controlled Substances Act (CSA). This means it is not subject to the stringent regulations that apply to opioids or benzodiazepines, which are categorized based on their potential for abuse, medical use, and safety. The federal government doesn't consider gabapentin (Neurontin) a controlled substance. However, gabapentin (Neurontin) has been shown to be potentually misused, such as causing a "high" when not used properly and when used at higher doses. Because of this risk, some states currently classify gabapentin (Neurontin) as a controlled substance Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970. 11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |